We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+12.77%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.58B
AUM Growth
-$4.87M
Cap. Flow
-$87.2M
Cap. Flow %
-3.38%
Top 10 Hldgs %
22.3%
Holding
280
New
32
Increased
93
Reduced
111
Closed
26

Top Buys

1
TMDX icon
Transmedics
TMDX
+$20.6M
2
BOOT icon
Boot Barn
BOOT
+$19.4M
3
TBBK icon
The Bancorp
TBBK
+$18.4M
4
SITM icon
SiTime
SITM
+$17.7M
5
ALGT icon
Allegiant Air
ALGT
+$17.2M

Top Sells

1
CRS icon
Carpenter Technology
CRS
+$26.4M
2
LBPH
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
+$22.8M
3
TNET icon
TriNet
TNET
+$19.6M
4
VKTX icon
Viking Therapeutics
VKTX
+$19.2M
5
CDMO
Avid Bioservices, Inc. Common Stock
CDMO
+$16.5M

Sector Composition

1 Technology 26.14%
2 Healthcare 24.06%
3 Industrials 19.5%
4 Financials 12.26%
5 Consumer Discretionary 6.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRDO icon
1
Credo Technology Group
CRDO
$37.8B
$92.5M 3.58%
1,376,927
-216,155
-14% -$10.7M
FTAI icon
2
FTAI Aviation
FTAI
$21.3B
$89.6M 3.47%
622,273
-6,659
-1% -$982K
FRPT icon
3
Freshpet
FRPT
$2.78B
$73.8M 2.86%
498,032
-15,972
-3% -$2.33M
QTWO icon
4
Q2 Holdings
QTWO
$3.43B
$48.7M 1.89%
484,314
-136,563
-22% -$13M
GTLS icon
5
Chart Industries
GTLS
$47.6M 1.84%
249,438
-3,223
-1% -$518K
INSM icon
6
Insmed
INSM
$23.5B
$47.3M 1.83%
684,636
-5,171
-0.7% -$372K
PLMR icon
7
Palomar
PLMR
$3.59B
$45.9M 1.78%
435,043
-14,930
-3% -$1.51M
RDNT icon
8
RadNet
RDNT
$4.89B
$45.9M 1.78%
657,189
-12,061
-2% -$890K
KTOS icon
9
Kratos Defense & Security Solutions
KTOS
$8.63B
$42.7M 1.66%
1,619,694
-121,557
-7% -$3.11M
SKWD icon
10
Skyward Specialty Insurance
SKWD
$2.4B
$41.6M 1.61%
823,404
-51,177
-6% -$2.49M
VRNS icon
11
Varonis Systems
VRNS
$5.46B
$41.1M 1.59%
925,542
-8,114
-0.9% -$422K
WVE icon
12
Wave Life Sciences
WVE
$1.12B
$39.1M 1.52%
3,162,369
+280,859
+10% +$3.75M
TVTX icon
13
Travere Therapeutics
TVTX
$5.27B
$37M 1.43%
2,125,744
+165,085
+8% +$2.92M
CRS icon
14
Carpenter Technology
CRS
$27.7B
$36.6M 1.42%
215,863
-154,143
-42% -$26.4M
ITCI
15
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$36.6M 1.42%
438,066
-3,230
-0.7% -$265K
BPMC
16
DELISTED
Blueprint Medicines
BPMC
$36.4M 1.41%
416,866
+41,000
+11% +$3.76M
LITE icon
17
Lumentum
LITE
$57B
$35.7M 1.38%
425,079
+46,544
+12% +$3.63M
LIVN icon
18
LivaNova
LIVN
$4.43B
$34.9M 1.35%
752,540
+57,035
+8% +$2.92M
BWIN
19
Baldwin Insurance Group
BWIN
$2.66B
$33.6M 1.3%
867,072
-17,227
-2% -$803K
AX icon
20
Axos Financial
AX
$5.66B
$33.5M 1.3%
479,120
-26,424
-5% -$1.93M
ATI icon
21
ATI
ATI
$25.4B
$33.1M 1.28%
602,039
-35,429
-6% -$2.09M
AVAV icon
22
AeroVironment
AVAV
$7.2B
$32.9M 1.28%
214,010
-3,656
-2% -$716K
VITL icon
23
Vital Farms
VITL
$581M
$32.6M 1.26%
864,323
+157,883
+22% +$5.61M
FOUR icon
24
Shift4
FOUR
$3.99B
$32.6M 1.26%
313,845
-84,962
-21% -$8.43M
BBIO icon
25
BridgeBio Pharma
BBIO
$15.9B
$31.6M 1.22%
1,150,868
+47,360
+4% +$1.22M
1
2 3 4 5

Similar funds

AWE
Avidian Wealth Enterprises Houston, Texas $3.16B AUM 20.31% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
BFA
Bragg Financial Advisors Charlotte, North Carolina $3.16B AUM 26% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Emerald Advisers's Q4 2024 Portfolio in Review

As of Q4 2024, Emerald Advisers held 280 positions worth $2.58B, down 0.19% from $2.59B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Emerald Advisers withdrew a net $87.2M in Q4 2024, closing 26 positions and reducing 111 holdings. Its most notable exit was Longboard Pharmaceuticals, Inc. Common Stock, an estimated $22.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Emerald Advisers opened a new position in Boot Barn worth $20M.

  • Emerald Advisers's largest Q4 2024 buy was Boot Barn: 131,637 shares worth $20M.
  • Emerald Advisers added most to Transmedics in Q4 2024, an estimated $20.6M increase.
  • Emerald Advisers's biggest Q4 2024 reduction was Carpenter Technology, cutting an estimated $26.4M.
  • Emerald Advisers fully exited Longboard Pharmaceuticals, Inc. Common Stock in Q4 2024, selling an estimated $22.8M.
  • Emerald Advisers's ten largest holdings make up 22% of its $2.58B portfolio in Q4 2024.
  • Emerald Advisers opened 32 new positions and closed 26 in Q4 2024.
  • Emerald Advisers's portfolio value fell 0.19% quarter-over-quarter to $2.58B.

Based on Emerald Advisers's 13F filing for Q4 2024, filed 11 Feb 2025.